Macular choroidal thickness and volume in normal subjects measured by swept-source optical coherence tomography

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 8, 2011, Pages 4971-4978

  Hirata, Masaya ^a   Tsujikawa, Akitaka ^a   Matsumoto, Akiko ^a,b   Hangai, Masanori ^a   Ooto, Sotaro ^a   Yamashiro, Kenji ^a   Akiba, Masahiro ^b   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOPCON CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGE; AGED; ARTICLE; CHOROIDAL VOLUME; EYE AXIS LENGTH; FEMALE; HUMAN; MACULAR CHOROIDAL THICKNESS; MALE; NORMAL HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REFRACTION ERROR; REPRODUCIBILITY; RETINA MACULA LUTEA; SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; AXIAL LENGTH, EYE; CHOROID; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MACULA LUTEA; MALE; MIDDLE AGED; OBSERVER VARIATION; ORGAN SIZE; PROSPECTIVE STUDIES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 79960037240     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7729     Document Type: Article

References (45)

1. Townsend KA, Wollstein G, Schuman JS. Clinical application of MRI in ophthalmology. NMR Biomed. 2008;21:997-1002.
2. Coleman DJ, Silverman RH, Chabi A, et al. High-resolution ultrasonic imaging of the posterior segment. Ophthalmology. 2004; 111:1344-1351.
3. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121:695-706.
4. Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahighand standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology. 2005;112:1922-1935.
5. Wojtkowski M, Bajraszewski T, Gorczynska I, et al. Ophthalmic imaging by spectral optical coherence tomography. Am J Ophthalmol. 2004;138:412-419.
6. Ikuno Y, Tano Y. Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:3876-3880.
7. Ikuno Y, Jo Y, Hamasaki T, Tano Y. Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci. 2010;51:3721-3725.
8. van Velthoven ME, Faber DJ, Verbraak FD, van Leeuwen TG, de Smet MD. Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res. 2007;26:57-77.
9. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496-500.
10. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009;147:644-652.
11. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811-815.
12. Reibaldi M, Boscia F, Avitabile T, et al. Enhanced depth imaging optical coherence tomography of the choroid in idiopathic macular hole: a cross-sectional prospective study. Am J Ophthalmol. 2011;151:112-117.
13. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011;31:510-517.
14. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117:1792-1799.
15. Imamura Y, Iida T, Maruko I, Zweifel SA, Spaide RF. Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol. 2011;151:297-302.
16. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011;118:840-845.
17. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. In press.
18. Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina. 2011;31:502-509.
19. Vance SK, Imamura Y, Freund KB. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina. 2011;31:332-335.
20. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009;148:445-450.
21. Yeoh J, Rahman W, Chen F, et al. Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2010;248:1719-1728.
22. Mwanza JC, Hochberg JT, Banitt MR, Feuer WJ, Budenz DL. Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:3430-3435.
23. Rahman W, Chen FK, Yeoh J, Patel P, Tufail A, Da Cruz L. Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52: 2267-2271.
24. McCourt EA, Cadena BC, Barnett CJ, Ciardella AP, Mandava N, Kahook MY. Measurement of subfoveal choroidal thickness using spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2010;41(suppl):S28-S33.
25. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469-1473.
26. Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2011; 151:594-603.
27. Yasuno Y, Okamoto F, Kawana K, Yatagai T, Oshika T. Investigation of multifocal choroiditis with panuveitis by three-dimensional high-penetration optical coherence tomography. J Biophotonics. 2009;2:435-441.
28. Esmaeelpour M, Povazay B, Hermann B, et al. Three-dimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. Invest Ophthalmol Vis Sci. 2010;51:5260-5266.
29. Povazay B, Bizheva K, Hermann B, et al. Enhanced visualization of choroidal vessels using ultrahigh resolution ophthalmic OCT at 1050 nm. Opt Express. 2003;11:1980-1986.
30. Huber R, Adler DC, Srinivasan VJ, Fujimoto JG. Fourier domain mode locking at 1050 nm for ultra-high-speed optical coherence tomography of the human retina at 236,000 axial scans per second. Opt Lett. 2007;32:2049-2051.
31. Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2010;51: 2173-2176.
32. Lee EC, de Boer JF, Mujat M, Lim H, Yun SH. In vivo optical frequency domain imaging of human retina and choroid. Opt Express. 2006;14:4403-4411.
33. Potsaid B, Baumann B, Huang D, et al. Ultrahigh speed 1050 nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express. 2010;18:20029-20048.
34. de Bruin DM, Burnes DL, Loewenstein J, et al. In vivo threedimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm. Invest Ophthalmol Vis Sci. 2008;49:4545-4552.
35. Srinivasan VJ, Huber R, Gorczynska I, et al. High-speed, highresolution optical coherence tomography retinal imaging with a frequency-swept laser at 850 nm. Opt Lett. 2007;32:361-363.
36. Unterhuber A, Povazay B, Hermann B, Sattmann H, Chavez-Pirson A, Drexler W. In vivo retinal optical coherence tomography at 1040 nm: enhanced penetration into the choroid. Opt Express. 2005;13:3252-3258.
37. Yasuno Y, Hong Y, Makita S, et al. In vivo high-contrast imaging of deep posterior eye by 1-micron swept source optical coherence tomography and scattering optical coherence angiography. Opt Express. 2007;15:6121-6139.
38. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985; 103:1796-1806.
39. Benavente-Perez A, Hosking SL, Logan NS, Bansal D. Reproducibility- repeatability of choroidal thickness calculation using optical coherence tomography. Optom Vis Sci. 2010;87:867-872.
40. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010;150:325-329.
41. Mylonas G, Ahlers C, Malamos P, et al. Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration. Br J Ophthalmol. 2009;93:1453-1460.
42. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144-168.
43. Spaide RF. Central serous chorioretinopathy. In: Holz FG, Spaide RF, eds. Medical Retina. Berlin: Springer-Verlag; 2004:77-93.
44. Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2005;45:115-134.
45. Quaranta M, Arnold J, Coscas G, et al. Indocyanine green angiographic features of pathologic myopia. Am J Ophthalmol. 1996; 122:663-671.